[en] Transforming growth factor-beta 1 (TGF beta 1) has been reported to have a strong inhibitory effect on the specific function of adrenal cells of several species. In the present study, we examined the effects of TGF beta 1 on cultured human fasciculata-reticularis cells. TGF beta 1 alone had no effect on ACTH receptor messenger ribonucleic acid (mRNA) levels and was unable to reduce the strong stimulatory effects of ACTH on its own receptor. However, TGF beta 1 enhanced angiotensin-II type 1 receptor mRNA and binding sites. Treatment with TGF beta 1 increased significantly the levels of 3 beta-hydroxysteroid dehydrogenase mRNA, reduced those of cytochrome P-450 17 alpha-hydroxylase mRNA, and had no effect on cholesterol side-chain cleavage cytochrome P-450 mRNA. Whatever the experimental condition, TGF beta 1 did not reduce basal or ACTH-stimulated cortisol production, but the production of dehydroepiandrosterone sulfate of TGF beta 1-treated cells was always decreased. The effects of TGF beta 1 on 3 beta-hydroxysteroid dehydrogenase mRNA and dehydroepiandrosterone sulfate were opposite the change observed at the time of adrenarche. As adrenal cells express TGF beta 1 mRNA, it is tempting to postulate that a local diminution of TGF beta 1 might be involved in adrenarche. Our findings also illustrate the specific species differences and, therefore, the caution to extrapolate to humans the results observed in other species.
Lyons RM, Moses HL. 1990 Transforming growth factors and the regulation of cell proliferation. Eur J Biochem. 187:467-473.
Massague J. 1990 The transforming growth factor-β family. Annu Rev Cell Biol. 6:597-641.
Roberts AB, Sporn MB. 1990 The transforming growth factors-β. In: Spom MB, Roberts AB, eds. Handbook of experimental pharmacology. New York: Springer-Verlag; vol 95/1:419-472.
Burt DW, Paton IR. 1992 Evolutionary origins of the transforming growth facor-d gene family. DNA Cell Biol. 11:497-510.
Wang XF, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA. 1991 Expression cloning and characterization of the TGβ type III receptor. Cell. 67:797-805.
Lopez-Casillas F, Cheifetz S, Doody J, Andres JL, Lane WS, Massague J. 1991 Structure, expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor system. Cell. 67:785-795.
Lin HY, Wang XF, Ng-Eaton E, Weinberg RA, Lodish HF. 1992 Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell. 68:775-785.
Ebner R, Chen RH, Shun L, et al. 1993 Cloning of a type I TGF-β receptor and its effects on TGF-β binding to the type II receptor. Sciences. 260:1344-1348.
Lopez-Casillas F, Wrana JL, Massague J. 1993 Betaglycan presents ligand to the TGFβ signaling receptor. Cell. 73:1435-1444.
Wrana JL, Attisano L, Carcamo J, et al. 1992 TGF-β signals through a heteromeric protein kinase receptor complex. Cell. 71:1003-1014.
Chen RH, Ebner R, Derinck R. 1993 Inactivation of the type II receptor reveals two receptors pathways for the diverse TGF-β activities. Science. 260:1335-1338.
Ying SY, Becker A, Baird A, et al. 1986 Type beta transforming growth factor (TGF-β) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system. Biochem Biophys Res Commun. 135:950-956.
Knecht M, Feng F, Catt KJ. 1986 Transforming growth factor-beta regulates the expresion of luteinzing hormone receptors in ovarian granulosa cells. Biochem Biophys Res Commun. 139:800-807.
Ying SY, Becker A, Ling N, Ueno N, Guillemen R. 1986 Inhibin and beta transforming growth factor (TGFβ) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity on cultured rat granulosa cells. Biochem Biophys Res Commun. 136:969-975.
Adashi EY, Resnick CE. 1986 Antagonistic interactions of transforming growth factors in the regulation of granulosa cell differentiation. Endocrinology. 119:1879-1881.
Lin T, Blaisdell J, Haskell JF. 1987 Transforming growth factor-β inhibits Leydig cell steroidogenesis in primary culture. Biochem Biophys Res Commun. 146:387-394.
Avallet O, Vigier M, Perrard-Sapori MH, Saez JM. 1987 Transforming growth factor 0 inhibits leydig cell functions. Biochem Biophys Res Commun. 146:575-581.
Hotta M, Baird A. 1986 Differential effects of transforming growth factor type β on the growth, function of adrenocortical cells, in vitro. Proc Natl Acad Sd USA. 83:7795-7799.
Rainey WE, Viard I, Mason JI, Cochet C, Chambaz EM, Saez JM. 1988 Effects of transforming growth factor beta on ovine adrenocortical cells. Mol Cell Endocrinol. 60:189-198.
Perrin A, Pascal O, Defaye G, Feige JJ, Chambaz EM. 1990 Transforming growth factor β1 is a negative regulator of steroid 17α-hydroxylase expression in bovine adrenocortical cells. Endocrinology. 128:357-362.
Rainey WE, Oka K, Magness RR, Mason JI. 1991 Ovine fetal adrenal synthesis of cortisol: regulation by adrenocorticotropin, angiotensin II, and transforming growth factor β. Endocrinology. 129:1784-1790.
Rainey WE, Naville D, Mason JI. 1991 Regulation of 3β -hydroxy-steroid dehydrogenase in adrenocortical cells: effects of angiotensin II and transforming growth factor beta. Endocr Res. 17:281-296.
Naville D, Rainey WE, Mason JI. 1991 Corticotropin regulation of 3β-hydroxysteroid dehydrogenase/A5-4-isomerase in ovine adrenocortical cells: inhibition by transforming growth factor β. Mol Cell Endocrinol. 75:257-263.
Rainey WE, Viard I, Saez JM. 1989 Transforming growth factor β treatment decreases ACTH receptors on ovine adrenocortical cells. J Biol Chem. 264:21474-21477.
Feige JJ, Cochet C, Savona C, et al. 1991 Transforming growth factor β1: an autocrine regulator of adrenocortical steroidogenesis. Endocr Res. 17:267-279.
Cochet C, Feige JJ, Chambaz EM. 1988 Bovine adrenocortical cells exhibit high affinity transforming growth factor-β receptors which are regulated by adrenocorticotropin. J Biol Chem. 263:5707-5713.
Keramidas M, Bourgarit JJ, Tabone E, Corticelli P, Chambaz EM, Feige JJ. 1991 Immunolocalization of transforming growth factor-β1 in the bovine adrenal cortex using antipeptide antibodies. Endocrinology. 129:517-526.
Parker LN. 1991 Adrenarche. Endocrinol Metab Clin North Am. 20:71-78.
Migeon CJ, Keller AR, Laurence B, Shepard THI. 1957 Dehydro-epiandrosterone and androsterone levels in human plasma. Effect of age and sex; day-to-day and diurnal variations. J Clin Endocrinol Metab. 17:1051-1056.
Luuthe V, Lachance Y, Labrie C, et al. 1989 Full length cDNA structure and deduced amino acid sequence of human 3β-hydroxy-5-ene steroid dehydrogenase. Mol Endocrinol. 3:1310-1312.
John ME, John MC, Ashley P, MacDonald RJ, Simpson ER, Waterman MR. 1984 Identification and characterization of cDNA clones specific for cholesterol side-chain cleavage cytochrome P-450. Proc Natl Acad Sci USA. 81:5628-5632.
Zubert MX, John ME, Okamura T, Simpson ER, Waterman MR. 1986 Bovine adrenocortical cytochrome P-45017α: regulation of gene expression and elucidation of primary sequence. J Biol Chem. 261:2475-2482.
Naville D, Lebrethon MC, Kermabon AY, Rouer E, Benarous R, Saez JM. 1993 Characterization and regulation of angiotensin II type 1 receptor (binding and mRNA) in human adrenal fasciculata-reticularis cells. FEBS Lett. 321:184-188.
Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. 1992 The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1248-1251.
Ouali R, Poulette S, Penhoat A, Saez JM. 1992 Characterization and coupling of angiotensin II receptor subtypes in cultured bovine adrenal fasciculata cells. J Steroid Biochem Biol. 43:271-280.
Penhoat A, Jaillard C, Crozat A, Saez JM. 1988 Regulation of angiotensin-II receptors and steroidogenic responsiveness in cultured bovine fasciculata and glomerulosa adrenal cells. Eur J Biochem. 172:247-254.
Raeside JI, Renaud RL. 1983 Estrogen and androgen production by purified Leydig cells of mature boars. Biol Reprod. 28:727-733.
Frolik CA, Wakefield LM, Smith DM, Sporn MB. 1984 Characterization of a membrane receptor for transforming growth factor-β in normal rat kidney fibroblasts. J Biol Chem. 259:10995-11000.
Pilch F, Czech M. 1980 The subunit structure of the high affinity insulin receptor. J Biol Chem. 255:1722-1731.
Chomczynski P, Sacchi N. 1987 Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem. 162:156-159.
Barbu V, Dautry F. 1989 Nothem blot normalization with 28S rRNA ologonucleotide probe. Nucleic Acids Res. 17:7115-7117.
Boyd FT, Massague J. 1989 Transforming growth factor-B inhibition of epithelial cell proliferayion linked to the expression of a 53-kD membrane receptor. J Biol Chem. 264:2272-2278.
Lebrethon MC, Naville D, Begeot M Saez JM. 1994 Regulation of corticotropin receptor number and mRNA in cultured human adrenocortical cells by corticotropin and angiotensin-II. J Clin Invest. 93:1828-1833.
Penhoat A, Jaillard C, Saez JM. 1994 Regulation of bovine adrenal cell corticotropin receptor mRNA levels by corticotropin (ACTH) and angiotensin-II (A-II). Mol Cell Endocrinol. 103:R7-R10.
Naseeruddin SA, Hornsby PJ. 1990 Regulation of lid- and 17a-hydroxylases in cultured bovine adrenocortical cells: 3'-5'-cyclic adenosine monophosphate, insulin-like growth factor-I, and activators of protein kinase C. Endocrinology. 127:1673-1681.
Lebrethon MC, Jaillard C, Defayes G, Begeot M, Saez JM. 1994 Human cultured adrenal fasciculata-reticularis cells are targets for angiotensin II: effects on P450scc (cholesterol side-chain cleavage), P45017α (17α-hydroxylase), 3 β-hydroxy steroid dehydrogenase mRNA and proteins and on steroidogenic responsiveness to corticotropin and angiotensin II. J Clin Endocrinol Metab. 78:1212-1219.
Rich BH, Rosenfield RL, Lucky AW, Helke JC, Otto P. 1981 Adrenarche: changing adrenal response to adrenocorticotropin. J Clin Endocrinol Metab. 52:1129-1136.